Access content directly

Giuseppe Ronzitti

24
Documents
Researcher identifiers

Presentation

Publications

Overcoming the Challenges Imposed by Humoral Immunity to AAV Vectors to Achieve Safe and Efficient Gene Transfer in Seropositive Patients

David-Alexandre Gross , Novella Tedesco , Christian Leborgne , Giuseppe Ronzitti
Frontiers in Immunology, 2022, 13, ⟨10.3389/fimmu.2022.857276⟩
Journal articles hal-03640310v1

Narrative review of glycogen storage disorder type III with a focus on neuromuscular, cardiac and therapeutic aspects

Édouard Berling , Pascal Laforêt , Karim Wahbi , Philippe H. Labrune , François Michael Petit
Journal of Inherited Metabolic Disease, 2021, 44 (3), pp.521-533. ⟨10.1002/jimd.12355⟩
Journal articles hal-03230901v1

AAV liver gene therapy-mediated inhibition of FGF23 signaling as a therapeutic strategy for X-linked hypophosphatemia

Volha Zhukouskaya , Louisa Jauze , Séverine Charles , Christian Leborgne , Stéphane Hilliquin
Endocrine Abstracts, 2021, ⟨10.1530/endoabs.73.OC6.2⟩
Journal articles inserm-03413999v1
Image document

Long-term correction of ornithine transcarbamylase deficiency in Spf-Ash mice with a translationally optimized AAV vector

Marcelo Simon Sola , Takashi Kei Kishimoto , Giulia de Sabbata , Florence Boisgérault , Corrado Guarnaccia
Molecular Therapy - Methods and Clinical Development, 2021, 20, pp.169 - 180. ⟨10.1016/j.omtm.2020.11.005⟩
Journal articles hal-03193757v1
Image document

Hepatic expression of GAA results in enhanced enzyme bioavailability in mice and non-human primates

Helena Costa-Verdera , Fanny Collaud , Christopher R Riling , Pauline Sellier , Jayme M L Nordin
Nature Communications, 2021, 12 (1), pp.6393. ⟨10.1038/s41467-021-26744-4⟩
Journal articles hal-03449262v1
Image document

A novel therapeutic strategy for skeletal disorders: Proof of concept of gene therapy for X-linked hypophosphatemia

Volha Zhukouskaya , Louisa Jauze , Séverine Charles , Christian Leborgne , Stéphane Hilliquin
Science Advances , 2021, 7 (44), pp.eabj5018. ⟨10.1126/sciadv.abj5018⟩
Journal articles inserm-03687057v1
Image document

Rescue of Advanced Pompe Disease in Mice with Hepatic Expression of Secretable Acid α-Glucosidase

Umut Cagin , Francesco Puzzo , Manuel Jose Gomez , Maryse Moya-Nilges , Pauline Sellier
Molecular Therapy, 2020, 28, pp.2056 - 2072. ⟨10.1016/j.ymthe.2020.05.025⟩
Journal articles hal-03491957v1
Image document

IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies

Christian Leborgne , Elena Barbon , Jeffrey M Alexander , Hayley Hanby , Sandrine Delignat
Nature Medicine, 2020, 26 (7), pp.1096-1101. ⟨10.1038/s41591-020-0911-7⟩
Journal articles hal-03031762v1
Image document

Preclinical Development of an AAV8-hUGT1A1 Vector for the Treatment of Crigler-Najjar Syndrome

Fanny Collaud , Giulia Bortolussi , Laurence Guianvarc'H , Sem Aronson , Thierry Bordet
Molecular Therapy - Methods and Clinical Development, 2019, 12, pp.157-174. ⟨10.1016/j.omtm.2018.12.011⟩
Journal articles hal-02179298v1
Image document

Role of Regulatory T Cell and Effector T Cell Exhaustion in Liver-Mediated Transgene Tolerance in Muscle

Jérôme Poupiot , Helena Costa Verdera , Romain Hardet , Pasqualina Colella , Fanny Collaud
Molecular Therapy - Methods and Clinical Development, 2019, 15, pp.83 - 100. ⟨10.1016/j.omtm.2019.08.012⟩
Journal articles hal-02392771v1

Deep morphological analysis of muscle biopsies from type III glycogenesis (GSDIII), debranching enzyme deficiency, revealed stereotyped vacuolar myopathy and autophagy impairment

Pascal Laforêt , Michio Inoue , Evelyne Goillot , Claire Lefeuvre , Umut Cagin
Acta Neuropathologica Communications, 2019, 7 (1), ⟨10.1186/s40478-019-0815-2⟩
Journal articles hal-02414161v1
Image document

Challenges of Gene Therapy for the Treatment of Glycogen Storage Diseases Type I and Type III

Louisa Jauze , Laure Monteillet , Gilles Mithieux , Fabienne Rajas , Giuseppe Ronzitti
Human Gene Therapy, 2019, 30 (10), pp.1263-1273. ⟨10.1089/hum.2019.102⟩
Journal articles inserm-02379154v1

Dual muscle-liver transduction imposes immune tolerance for muscle transgene engraftment despite preexisting immunity

Laurent Bartolo , Stéphanie Li Chung Tong , Pascal Chappert , Dominique Urbain , Fanny Collaud
JCI Insight, 2019, 4 (11), pii: 127008. ⟨10.1172/jci.insight.127008⟩
Journal articles hal-02332827v1
Image document

Real-Time Monitoring of Exosome Enveloped-AAV Spreading by Endomicroscopy Approach: A New Tool for Gene Delivery in the Brain

Nicola Salvatore Orefice , Benoît Souchet , Jérôme Braudeau , Sandro Alves , Françoise Piguet
Molecular Therapy - Methods and Clinical Development, 2019, 14, pp.237 - 251. ⟨10.1016/j.omtm.2019.06.005⟩
Journal articles cea-02997523v1

Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration

Florence Boisgérault , Amine Meliani , Romain Hardet , Solenne Marmier , Fanny Collaud
Nature Communications, 2018, 9 (1), pp.4098. ⟨10.1038/s41467-018-06621-3⟩
Journal articles hal-02177709v1
Image document

Emerging Issues in AAV-Mediated In Vivo Gene Therapy

Pasqualina Colella , Giuseppe Ronzitti , Federico Mingozzi
Molecular Therapy - Methods and Clinical Development, 2018, 8, pp.87-104. ⟨10.1016/j.omtm.2017.11.007⟩
Journal articles hal-01812088v1
Image document

Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction

Zachary Fitzpatrick , Christian Leborgne , Elena Barbon , Elisa Masat , Giuseppe Ronzitti
Molecular Therapy - Methods and Clinical Development, 2018, 9, pp.119-129. ⟨10.1016/j.omtm.2018.02.003⟩
Journal articles hal-01830017v1

Rescue of GSDIII Phenotype with Gene Transfer Requires Liver- and Muscle-Targeted GDE Expression

Patrice Vidal , Serena Pagliarani , Pasqualina Colella , Helena Costa Verdera , Louisa Jauze
Molecular Therapy, 2018, 26 (3), pp.890-901. ⟨10.1016/j.ymthe.2017.12.019⟩
Journal articles hal-02332988v1

Exposure to wild-type AAV drives distinct capsid immunity profiles in humans

Klaudia Kuranda , Priscilla Jean-Alphonse , Christian Leborgne , Romain Hardet , Fanny Collaud
Journal of Clinical Investigation, 2018, 128 (12), pp.5267-5279. ⟨10.1172/JCI122372⟩
Journal articles hal-01977027v1
Image document

Low-dose liver targeted gene therapy for Pompe disease enhances therapeutic efficacy of ERT via immune tolerance induction

Sang-Oh Han , Giuseppe Ronzitti , Benjamin Arnson , Christian Leborgne , Songtao Li
Molecular Therapy - Methods and Clinical Development, 2017, ⟨10.1016/j.omtm.2016.12.010⟩
Journal articles hal-01432085v1

Enhanced liver gene transfer and evasion of preexisting humoral immunity with exosome-enveloped AAV vectors

Amine Meliani , Florence Boisgérault , Zachary Fitzpatrick , Solenne Marmier , Christian Leborgne
Blood Advances, 2017, 1 (23), pp.2019-2031. ⟨10.1182/bloodadvances.2017010181⟩
Journal articles hal-02377508v1
Image document

Transposon-mediated Generation of Cellular and Mouse Models of Splicing Mutations to Assess the Efficacy of snRNA-based Therapeutics

Elena Barbon , Mattia Ferrarese , Laetitia van Wittenberghe , Peggy Sanatine , Giuseppe Ronzitti
Molecular Therapy - Nucleic Acids, 2016, 5, pp.e392. ⟨10.1038/mtna.2016.97⟩
Journal articles hal-01449506v1
Image document

Long-term exposure to Myozyme results in a decrease of anti-drug antibodies in late-onset Pompe disease patients

Elisa Masat , Pascal Laforêt , Marie de Antonio , Guillaume Corre , Barbara Perniconi
Scientific Reports, 2016, 6, pp.36182. ⟨10.1038/srep36182⟩
Journal articles hal-01404918v1
Image document

A translationally optimized AAV-UGT1A1 vector drives safe and long-lasting correction of Crigler-Najjar syndrome

Giuseppe Ronzitti , Giulia Bortolussi , Remco van Dijk , Fanny Collaud , Severine Charles
Molecular Therapy - Methods and Clinical Development, 2016, 3, ⟨10.1038/mtm.2016.49⟩
Journal articles hal-01474146v1